Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • Publications
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Presentations
    • Overview
    • Press Releases
    • IR Calendar
    • Safe Harbor Statement
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Management Team
    • Contacts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Presentations
  • Overview
  • Press Releases
  • IR Calendar
  • Safe Harbor Statement
  • Email Alerts

Navidea Reports Preliminary 2014 Revenue; Provides Update on New Commercial Strategy

Feb 9, 2015

Navidea to Report Preliminary 2014 Revenue and Present at BIO CEO & Investor Conference February 9

Feb 2, 2015

Lymphoseek® Performance vs. Sulfur Colloid in Breast Cancer Patients Published in Annals of Surgical Oncology; Fewer Nodal Dissections Required

Jan 29, 2015

Navidea’s Macrophage Therapeutics Unit Announces Plan for $2.5 Million Financing

Jan 21, 2015

Navidea Biopharmaceuticals to Present at Biotech Showcase 2015

Jan 6, 2015

Navidea Strengthens Leadership Team to Accelerate Lymphoseek® Growth

Jan 5, 2015

Data Presented by Independent Academic Collaborators Demonstrate Ability of Novel Manocept™ Immunotherapy to Kill Activated Macrophages from KS Patients

Dec 15, 2014

Macrophage Therapeutics to Present Data Supporting Potential for Breakthrough with Manocept™ in Immunotherapy

Dec 12, 2014

Navidea Forms Macrophage Therapeutics Business Unit to Explore Therapeutic Applications of Manocept™

Dec 10, 2014

Navidea Biopharmaceuticals to Present at the 2014 LD Micro Conference

Nov 25, 2014
RSS
    • 1...
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    • 33
    • ...45
    © 2025 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    linkedin
    Privacy Policy Disclaimer Sitemap